The INNO-LiPA HBV-DR assay is superior to sequencing for the detection of YMDD-mutants
H.L. Tillmann, H. Wedemeyer, C.T. Bock, A. Finger, I. Glomb, P. Magerstest, C. Trautwein, M.P. MannsVolume:
38
Year:
2003
Language:
english
DOI:
10.1016/s0168-8278(03)80874-7
File:
PDF, 320 KB
english, 2003